LIQUID CRYSTAL MEDIUM, METHOD FOR THE STABILISATION THEREOF AND LIQUID CRYSTAL DISPLAY

Liquid crystalline medium comprises (a) at least one substituted piperidine derivative (I) excluding substituted carbonic acid dipiperidin-4-yl ester compounds (Ia), and (b) at least one substituted 1-cyclohexylmethoxy-2,3-difluoro-benzene derivative (II). Liquid crystalline medium comprises (a) at...

Full description

Saved in:
Bibliographic Details
Main Authors Fortte, Rocco, Goebel, Mark, Pauluth, Detlef, Baron, Eveline
Format Patent
LanguageEnglish
French
German
Published 14.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Liquid crystalline medium comprises (a) at least one substituted piperidine derivative (I) excluding substituted carbonic acid dipiperidin-4-yl ester compounds (Ia), and (b) at least one substituted 1-cyclohexylmethoxy-2,3-difluoro-benzene derivative (II). Liquid crystalline medium comprises (a) at least one substituted piperidine derivative of formula (I) excluding substituted carbonic acid dipiperidin-4-yl ester compounds of formula (Ia), and (b) at least one substituted 1-cyclohexylmethoxy-2,3-difluoro-benzene derivative of formula (II). n : 1-4; m : 4-n; Z1 : organic group having 4 binding sites; Z11, Z12 : -O-, -(C=O)-, -(N-R14)- or single bond, where Z11 and Z12 do not simultaneously represent -O-; r, s : 0 or 1; either Y11-Y14 : 1-4C alkyl; or Y11+Y12, Y13+Y14 : 3-6C divalent group; R11 : O-R13, oxygen free radical or OH, preferably O-R13, preferably isopropyloxy, cyclohexyloxy, acetophenyl-oxy or benzyloxy, or oxygen free radical (preferred); R12 : H, F, OR14, NR14R15, 1-20C alkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where two adjacent CH 2 groups are not optionally replaced by -O-), hydrocarbyl, preferably cycloalkyl or alkyl-cycloalkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where 2 adjacent CH 2 groups are not optionally replaced by -O-, and 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16) or (hetero)aromatic hydrocarbyl (in which 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16); R13 : 1-20C alkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where two adjacent CH 2 groups are not optionally replaced by -O-), hydrocarbyl, preferably cycloalkyl or alkyl-cycloalkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where 2 adjacent CH 2 groups are not optionally replaced by -O-, and 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16), (hetero)aromatic hydrocarbyl (in which 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16), 1,4-cyclohexylene (in which at least one CH 2 group is optionally replaced by -O-, -CO- or -NR14-) or acetophenyl, isopropyl or 3-heptyl; R14, R15 : 1-10C alkyl, 1-10C acyl, aromatic 6-12C hydrocarbyl or 6-12C carboxylic acid; R16 : 1-10C alkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where 2 adjacent CH 2 groups are not optionally replaced by -O-); G : oxygen free radical; G1 : 1-4C alkyl; R41 : unsubstituted 1-7C alkenyl; R42 : 1-7C alkyl, 1-6C alkoxy or 2-6C alkenyloxy (all unsubstituted); and i : 0 or 1. Provided that when n is 1, R11 is oxygen free radical and -[Z11] r-[Z12] s is -O-, -(CO)-O-, -O-(CO)-, -O-(CO)-O-, -NR14- or -NR14-(CO)-, then [R12] m-Z1 is not 1-10C alkyl, cycloalkyl, cycloalkylalkyl or alkyl-cycloalkyl (in all groups at least one CH 2 group is optionally replaced by -O- such that two O atoms are not directly bonded with each other); and when n is 2 and R11 is O-R13, then R13 is not nitrogen-1-9C alkyl. Independent claims are also included for: (1) an electro-optical display or an electro-optical component comprising the above liquid crystalline medium; (2) preparing the liquid crystalline medium, comprising mixing (I) with (II), substituted bicyclohexyl compounds of formula (IVb) and/or substituted 1-cyclohexyl-2,3-difluorobenzene derivatives of formula (IIIa), substituted 1-cyclohex-1-enyl-2,3-difluorobenzene derivatives of formula (IIIb), substituted 2,3-difluoro-biphenyl derivatives of formula (IIIc) or substituted 2',3'-difluoro-[1,1';4',1'']terphenyl compounds of formula (IIId); and (3) stabilizing the liquid crystalline medium, comprising adding a medium which comprises (I) and optionally 2,6-di-tert-butyl-4-(4-propyl-cyclohexyl)-phenol, 2,6-di-tert-butyl-4-(5-propyl-[1,3]dioxan-2-yl)-phenol, 3,5-di-tert-butyl-4-hydroxy-benzoic acid hexadecyl ester, 3,5-di-tert-butyl-4-hydroxy-benzoic acid 4-pentyl-cyclohexylmethyl ester, 2,5-bis-(1,1,3,3-tetramethyl-butyl)-benzene-1,4-diol and acrylic acid 2-tert-butyl-6-(3-tert-butyl-2-hydroxy-5-methyl-benzyl)-4-methyl-phenyl ester to a medium which comprises (II). R31 : unsubstituted 1-7C alkyl; R32 : 1-7C alkyl or 1-6C alkoxy (both unsubstituted); m, n, o : 0 or 1; R51 : 1-7C alkyl or 2-7C alkenyl (both unsubstituted); and R52 : unsubstituted 2-7C alkenyl. [Image] [Image] [Image].
AbstractList Liquid crystalline medium comprises (a) at least one substituted piperidine derivative (I) excluding substituted carbonic acid dipiperidin-4-yl ester compounds (Ia), and (b) at least one substituted 1-cyclohexylmethoxy-2,3-difluoro-benzene derivative (II). Liquid crystalline medium comprises (a) at least one substituted piperidine derivative of formula (I) excluding substituted carbonic acid dipiperidin-4-yl ester compounds of formula (Ia), and (b) at least one substituted 1-cyclohexylmethoxy-2,3-difluoro-benzene derivative of formula (II). n : 1-4; m : 4-n; Z1 : organic group having 4 binding sites; Z11, Z12 : -O-, -(C=O)-, -(N-R14)- or single bond, where Z11 and Z12 do not simultaneously represent -O-; r, s : 0 or 1; either Y11-Y14 : 1-4C alkyl; or Y11+Y12, Y13+Y14 : 3-6C divalent group; R11 : O-R13, oxygen free radical or OH, preferably O-R13, preferably isopropyloxy, cyclohexyloxy, acetophenyl-oxy or benzyloxy, or oxygen free radical (preferred); R12 : H, F, OR14, NR14R15, 1-20C alkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where two adjacent CH 2 groups are not optionally replaced by -O-), hydrocarbyl, preferably cycloalkyl or alkyl-cycloalkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where 2 adjacent CH 2 groups are not optionally replaced by -O-, and 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16) or (hetero)aromatic hydrocarbyl (in which 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16); R13 : 1-20C alkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where two adjacent CH 2 groups are not optionally replaced by -O-), hydrocarbyl, preferably cycloalkyl or alkyl-cycloalkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where 2 adjacent CH 2 groups are not optionally replaced by -O-, and 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16), (hetero)aromatic hydrocarbyl (in which 1 H or several H are optionally replaced by OR14, N(R14)(R15) or R16), 1,4-cyclohexylene (in which at least one CH 2 group is optionally replaced by -O-, -CO- or -NR14-) or acetophenyl, isopropyl or 3-heptyl; R14, R15 : 1-10C alkyl, 1-10C acyl, aromatic 6-12C hydrocarbyl or 6-12C carboxylic acid; R16 : 1-10C alkyl (in which 1 CH 2 group or several CH 2 groups are optionally replaced by -O- or -C(=O)-, where 2 adjacent CH 2 groups are not optionally replaced by -O-); G : oxygen free radical; G1 : 1-4C alkyl; R41 : unsubstituted 1-7C alkenyl; R42 : 1-7C alkyl, 1-6C alkoxy or 2-6C alkenyloxy (all unsubstituted); and i : 0 or 1. Provided that when n is 1, R11 is oxygen free radical and -[Z11] r-[Z12] s is -O-, -(CO)-O-, -O-(CO)-, -O-(CO)-O-, -NR14- or -NR14-(CO)-, then [R12] m-Z1 is not 1-10C alkyl, cycloalkyl, cycloalkylalkyl or alkyl-cycloalkyl (in all groups at least one CH 2 group is optionally replaced by -O- such that two O atoms are not directly bonded with each other); and when n is 2 and R11 is O-R13, then R13 is not nitrogen-1-9C alkyl. Independent claims are also included for: (1) an electro-optical display or an electro-optical component comprising the above liquid crystalline medium; (2) preparing the liquid crystalline medium, comprising mixing (I) with (II), substituted bicyclohexyl compounds of formula (IVb) and/or substituted 1-cyclohexyl-2,3-difluorobenzene derivatives of formula (IIIa), substituted 1-cyclohex-1-enyl-2,3-difluorobenzene derivatives of formula (IIIb), substituted 2,3-difluoro-biphenyl derivatives of formula (IIIc) or substituted 2',3'-difluoro-[1,1';4',1'']terphenyl compounds of formula (IIId); and (3) stabilizing the liquid crystalline medium, comprising adding a medium which comprises (I) and optionally 2,6-di-tert-butyl-4-(4-propyl-cyclohexyl)-phenol, 2,6-di-tert-butyl-4-(5-propyl-[1,3]dioxan-2-yl)-phenol, 3,5-di-tert-butyl-4-hydroxy-benzoic acid hexadecyl ester, 3,5-di-tert-butyl-4-hydroxy-benzoic acid 4-pentyl-cyclohexylmethyl ester, 2,5-bis-(1,1,3,3-tetramethyl-butyl)-benzene-1,4-diol and acrylic acid 2-tert-butyl-6-(3-tert-butyl-2-hydroxy-5-methyl-benzyl)-4-methyl-phenyl ester to a medium which comprises (II). R31 : unsubstituted 1-7C alkyl; R32 : 1-7C alkyl or 1-6C alkoxy (both unsubstituted); m, n, o : 0 or 1; R51 : 1-7C alkyl or 2-7C alkenyl (both unsubstituted); and R52 : unsubstituted 2-7C alkenyl. [Image] [Image] [Image].
Author Goebel, Mark
Fortte, Rocco
Baron, Eveline
Pauluth, Detlef
Author_xml – fullname: Fortte, Rocco
– fullname: Goebel, Mark
– fullname: Pauluth, Detlef
– fullname: Baron, Eveline
BookMark eNrjYmDJy89L5WQI8_EMDPV0UXAOigwOcfRR8HV18Qz11QHSIR7-Lgpu_kEKIR6uCkA5J08fz2DHEE9_P5BIkKu_m4Kjn4sCmn4Xz-AAH8dIHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oS7xpgbGxkbmhg7GRoTIQSAGZEMgE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FLÜSSIGKRISTALLINES MEDIUM, METHODE ZU SEINER STABILISIERUNG UND FLÜSSIGKRISTALLANZEIGE
FLUIDE À BASE DE CRISTAUX LIQUIDES, SON PROCÉDÉ DE STABILISATION ET AFFICHAGE À BASE DE CRISTAUX LIQUIDES
ExternalDocumentID EP3327103B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3327103B13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:11:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3327103B13
Notes Application Number: EP20170208222
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201014&DB=EPODOC&CC=EP&NR=3327103B1
ParticipantIDs epo_espacenet_EP3327103B1
PublicationCentury 2000
PublicationDate 20201014
PublicationDateYYYYMMDD 2020-10-14
PublicationDate_xml – month: 10
  year: 2020
  text: 20201014
  day: 14
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Merck Patent GmbH
RelatedCompanies_xml – name: Merck Patent GmbH
Score 3.3001518
Snippet Liquid crystalline medium comprises (a) at least one substituted piperidine derivative (I) excluding substituted carbonic acid dipiperidin-4-yl ester compounds...
SourceID epo
SourceType Open Access Repository
SubjectTerms ADHESIVES
CHEMISTRY
DYES
ELECTRIC COMMUNICATION TECHNIQUE
ELECTRICITY
MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FORELSEWHERE
METALLURGY
MISCELLANEOUS APPLICATIONS OF MATERIALS
MISCELLANEOUS COMPOSITIONS
NATURAL RESINS
PAINTS
POLISHES
TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHICCOMMUNICATION
Title LIQUID CRYSTAL MEDIUM, METHOD FOR THE STABILISATION THEREOF AND LIQUID CRYSTAL DISPLAY
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201014&DB=EPODOC&locale=&CC=EP&NR=3327103B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DedivOLPEifLNamXfdSZG1aWtnWubVjPo2lzWAv23AV_76X2E0R9CnhjhzJweU-cncBuDPbM4tSy9CFzbkun850ngtLN0zu2I7IZ1_BnF6_FWXW88Se1GCxrYVRfUI_VHNElKgc5b1U9_X6O4jFVG7l5oEvELR6ClOXaZV3bKqvZzXmucEgYYmv-T7OtP7QpdREXUo9dJT2pBUt2-wHY08Wpax_apTwGPYHSGxZnkCtEA049LcfrzXgoFe9d-O0Er3NKYy78UsWM-IPX0dpp0tkX8asd49jGiWMoDNH0iggiPPibjxSoScJGQZJSDp9Rn6tr9JGzoCEQepHOm5wumPGNBjsjkLPob5cLcUFkDmns6JtOBz9EatoFW3Uulw4czSQkPO2aELzTzKX_-Cu4EhyVV7Wj9Y11Mu3d3GDWrjkt4p_n4sJhHQ
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbnxE_-2D25CKuG-OFGLZu2XQfCIPgE6GsJLwAkRn_fa91oDHRp17atGkvubv-7to7gFujNTEpNRu6sDjXZehM51Nh6g2D25YtppMvZ06cNIOB-TSyRhWYb_7CqDyhHyo5IkrUFOW9UPp69e3EYupt5fqez7Fr-ehnbaaV6NhQpWc15rS9bspSV3NdpLSk16bUQFtKHQRKOzYiQplm3xs68lPK6qdF8Q9gt4uLLYpDqOTiCGrupvDaEezFZbwbyVL01scwjMKXQciI23vtZ52IyLyMg_gO2yxIGUEwR7LAIzjmhFHYV64n2dPzUp90EkZ-zS-fjZwA8b3MDXTc4HjLjLHX3R6FnkJ1sVyIMyAzTid5q2FzxCNm3sxbaHW5sGd4QULOW6IO9T-XOf9n7AZqQRZH4yhMni9gX3JYKu4H8xKqxdu7uEKLXPBrxctP40qHXw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=LIQUID+CRYSTAL+MEDIUM%2C+METHOD+FOR+THE+STABILISATION+THEREOF+AND+LIQUID+CRYSTAL+DISPLAY&rft.inventor=Fortte%2C+Rocco&rft.inventor=Goebel%2C+Mark&rft.inventor=Pauluth%2C+Detlef&rft.inventor=Baron%2C+Eveline&rft.date=2020-10-14&rft.externalDBID=B1&rft.externalDocID=EP3327103B1